Kikuchi Y, Hirose J, Uekita Y, Hayasaka K, Asano A, Nishino S, Mitsuhashi H, Amo K, Washizuka N, Mure I, Yamashita Y
Gan No Rinsho. 1983 Apr;29(4):A-21, 330-5.
Serum CEA levels were measured in the blood of 98 patients with uterine cervix cancer before, during, and after treatment to investigate the relationship among the CEA level, the extent of the disease, and recovery. The CEA level rose as the disease progressed. Although there was no significant difference in the survival rates of patients with various CEA levels, those who returned to normal levels after treatment recuperated better. There was not clear evidence that CEA levels are clinically significant. However, it can be concluded that CEA levels at pre- and post-treatment times are helpful in the early detection of disease, prognosis, and in predicting recurrence or metastasis.
检测了98例宫颈癌患者治疗前、治疗期间及治疗后的血清癌胚抗原(CEA)水平,以研究CEA水平、疾病程度和恢复情况之间的关系。随着疾病进展,CEA水平升高。尽管不同CEA水平患者的生存率无显著差异,但治疗后CEA水平恢复正常的患者恢复得更好。尚无明确证据表明CEA水平具有临床意义。然而,可以得出结论,治疗前后的CEA水平有助于疾病的早期检测、预后评估以及预测复发或转移。